tiprankstipranks
Avicanna Strengthens Leadership and Expands Portfolio
Company Announcements

Avicanna Strengthens Leadership and Expands Portfolio

Story Highlights

Avicanna (TSE:AVCN) has released an update.

Don't Miss our Black Friday Offers:

Avicanna Inc., a leader in cannabinoid-based biopharmaceuticals, successfully elected its management’s nominees as company directors and reaffirmed its auditor appointment during the Annual General Meeting. The company continues to progress in the medical cannabis industry with an expanding portfolio, including the RHO Phyto formulary and the MyMedi.ca care platform.

For further insights into TSE:AVCN stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskAvicanna Shows Strong Revenue Growth and Improved Margins
TipRanks Canadian Auto-Generated NewsdeskAvicanna Secures $800K in Private Placement
TipRanks Canadian Auto-Generated NewsdeskAvicanna Launches Major Cannabis Effects Study
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App